Altamira Therapeutics CYTOF
OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Altamira Therapeutics Ltd. (CYTOF) Receivables - Other (2021 - 2024)

Updated

Altamira Therapeutics' Receivables - Other was $351,331 in Q4 2024, up 316.5% from $84,352 a year earlier.

Analysis

Altamira Therapeutics Ltd. (CYTOF) Receivables - Other (2021 - 2024) Analysis & Trends

From Q4 2021 onward, Altamira Therapeutics has reported Receivables - Other for 4 quarters.

  • Receivables - Other shows a three-year compound annual growth rate of -21.6% (FY2021 to FY2024).
  • In earlier years, Receivables - Other was $88,916 in FY2023 (-88.7%), $784,731 in FY2022 (+7.8%) and $728,070 in FY2021.
  • The Q4 2024 figure marks the highest quarterly Receivables - Other since Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 351,331.00
Dec 31, 2023 88,720.12
Dec 31, 2022 819,187.28
Dec 31, 2021 734,748.86
API Access

Altamira Therapeutics Ltd. Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CYTOF&period=max&api_key=YOUR_API_KEY